Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
First Bancorp
FBNC
$2.68B
| $3.05M | ﹤0.01% |
82,485
+22,015
| +36% | +$691K |
|
2502
PUT
KB Home
KBH
$3.59B
| $3.05M | ﹤0.01% |
+48,800
| New | +$2.51M |
|
2503
PUT
Compañía de Minas Buenaventura
BVN
$8.67B
| $3.05M | ﹤0.01% |
+200,000
| New | +$1.93M |
|
2504
Bread Financial
BFH
$4.38B
| $3.04M | ﹤0.01% |
92,241
-49,238
| -35% | -$1.47M |
|
2505
CALL
MasTec
MTZ
$21.9B
| $3.03M | ﹤0.01% |
+40,000
| New | +$2.5M |
|
|
2506
PUT
MasTec
MTZ
$21.9B
| $3.03M | ﹤0.01% |
+40,000
| New | +$2.5M |
|
|
ROIC
2507
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.03M | ﹤0.01% |
215,857
+151,017
| +233% | +$1.9M |
|
2508
IAMGOLD
IAG
$10.5B
| $3.03M | ﹤0.01% |
1,196,710
+903,347
| +308% | +$2.17M |
|
2509
Chegg
CHGG
$102M
| $3.02M | ﹤0.01% |
265,910
+121,239
| +84% | +$1.15M |
|
2510
ProShares S&P 500 ex-Health Care ETF
SPXV
$41.6M
| $3.02M | ﹤0.01% |
60,000
| – | – |
|
2511
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| $3.01M | ﹤0.01% |
38,904
-30,426
| -44% | -$2.3M |
|
2512
Comstock Resources
CRK
$3.94B
| $3.01M | ﹤0.01% |
339,960
+13,474
| +4% | +$146K |
|
2513
BlueLinx
BXC
$706M
| $3.01M | ﹤0.01% |
26,549
+14,809
| +126% | +$1.28M |
|
2514
CALL
Zimmer Biomet
ZBH
$18.4B
| $3.01M | ﹤0.01% |
+24,700
| New | +$2.76M |
|
2515
TechnipFMC
FTI
$27.3B
| $3M | ﹤0.01% |
149,044
+29,258
| +24% | +$599K |
|
2516
Element Solutions
ESI
$9.23B
| $2.98M | ﹤0.01% |
128,955
-127,884
| -50% | -$2.58M |
|
2517
Kura Oncology
KURA
$850M
| $2.98M | ﹤0.01% |
207,272
+52,027
| +34% | +$512K |
|
2518
Hims & Hers Health
HIMS
$7.31B
| $2.98M | ﹤0.01% |
334,827
+23,506
| +8% | +$174K |
|
2519
Enerpac Tool Group
EPAC
$1.93B
| $2.98M | ﹤0.01% |
95,837
+60,688
| +173% | +$1.73M |
|
2520
Supernus Pharmaceuticals
SUPN
$2.77B
| $2.98M | ﹤0.01% |
102,799
+47,955
| +87% | +$1.27M |
|
2521
Agilysys
AGYS
$3.06B
| $2.97M | ﹤0.01% |
34,972
+22,302
| +176% | +$1.81M |
|
2522
Dillards
DDS
$9.56B
| $2.97M | ﹤0.01% |
7,346
+2,747
| +60% | +$932K |
|
2523
Howard Hughes
HHH
$4.03B
| $2.96M | ﹤0.01% |
+36,333
| New | +$2.55M |
|
2524
Franco-Nevada
FNV
$46B
| $2.96M | ﹤0.01% |
26,724
+20,399
| +323% | +$2.48M |
|
2525
PUT
Shell
SHEL
$245B
| $2.96M | ﹤0.01% |
45,000
-45,000
| -50% | -$2.95M |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.